Title: Changes in CGM Metrics for People with T2D Switching from Dulaglutide or Semaglutide to Tirzepatide 5mg A Sub-Analysis of The Surpass-Switch-2 Study
e-poster Number: A-441800-RSSDI2025
Category: E-poster
Author Name: Dr Swati Choudhary
Institute: Eli Lilly and Company
Co-Author Name:
